Preparing for phase II/III HIV vaccine trials in Africa
Eftyhia Vardas(University of the Witwatersrand), Mario Clerici(University of Milan), Guido Poli(University of Verona), Stefano Buttò, Richard H. Glashoff(Stellenbosch University), Mauro Malnati(Vita-Salute San Raffaele University)
Cited by 11
Related Papers
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
|Immunity|1995|574
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
CD46 Is a Cellular Receptor for Human Herpesvirus 6
|Cell|1999|525
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
|The Lancet Infectious Diseases|2018|415